Your browser doesn't support javascript.
loading
Thymocyte selection-associated high mobility box protein regulates T lymphocytes exhaustion in patients with myelodysplastic syndromes by inhibiting PI3K/AKT/mTOR pathway.
Niu, Haiyue; Zhang, Mengying; Liu, Mengyuan; Yang, Liyan; Yang, Liping; Ren, Jie; Yu, Yating; Liu, Yumei; Xing, Limin; Shao, Zonghong; Wang, Huaquan.
Afiliación
  • Niu H; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Zhang M; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Liu M; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Yang L; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Yang L; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Ren J; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Yu Y; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Liu Y; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Xing L; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Shao Z; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
  • Wang H; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, China.
Hematol Oncol ; 42(1): e3224, 2024 Jan.
Article en En | MEDLINE | ID: mdl-37712442

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Proteínas Proto-Oncogénicas c-akt Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Proteínas Proto-Oncogénicas c-akt Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido